Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Breathe (Sheffield, England)|November 20, 2025
First episode of psychosis in a patient undergoing tuberculosis treatmentJohn Murray, Lorraine Dolan, Ciara MacKenna, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2002
Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient miceEdgar C Lucey, Joseph Keane, Ping-Ping Kuang, et al.
Infection and Immunity|March 16, 2002
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growthJussi J Saukkonen, Beth Bazydlo, Michael Thomas, et al.
General Hospital Psychiatry|May 11, 2013
A review of the interplay between tuberculosis and mental healthAnne M Doherty, John Kelly, Colm McDonald, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 29, 2026
Human Macrophages Secrete Both Interferon α and Interferon β Proteins During Infection with <i>Mycobacterium tuberculosis</i>Gina Leisching, Donal Cox, Vincent Bondet, et al.
American Journal of Respiratory and Critical Care Medicine|December 24, 2010
Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionAsha Anandaiah, Keertan Dheda, Joseph Keane, et al.
American Journal of Respiratory Cell and Molecular Biology|May 16, 2003
Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factorAvrum Spira, J David Carroll, Gang Liu, et al.
The Open Respiratory Medicine Journal|April 3, 2009
Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in IrelandAnne Marie Mc Laughlin, Rory A O'Donnell, Noel Gibbons, et al.
QJM : Monthly Journal of the Association of Physicians|December 18, 2025
Whole genome sequencing confirms reactivation of Tuberculosis five years after initial infection despite adequate preventative therapy in a patient with profound immunosuppressionEmma Mcnally, Sarahjane O'Riordan, Margaret Fitzgibbon, et al.
Pageof 9